The H50Q Mutation Induces a 10-fold Decrease in the Solubility of α-Synuclein
Riccardo Porcari, Christos Proukakis, Christopher A. Waudby et al. · Journal of Biological Chemistry · 2014
The conversion of α-synuclein from its intrinsically disordered monomeric state into the fibrillar cross-β aggregates characteristically present in Lewy bodies is largely unknown. The investigation of α-synuclein variants causative of familial forms of Parkinson disease can provide unique insights into the conditions that promote or inhibit aggregate formation. It has been shown recently that a newly identified pathogenic mutation of α-synuclein, H50Q, aggregates faster than the wild-type. We investigate here its aggregation propensity by using a sequence-based prediction algorithm, NMR chemical shift analysis of secondary structure populations in the monomeric state, and determination of thermodynamic stability of the fibrils. Our data show that the H50Q mutation induces only a small increment in polyproline II structure around the site of the mutation and a slight increase in the overall aggregation propensity. We also find, however, that the H50Q mutation strongly stabilizes α-synuclein fibrils by 5.0 ± 1.0 kJ mol −1 , thus increasing the supersaturation of monomeric α-synuclein within the cell, and strongly favors its aggregation process. We further show that wild-type α-synuclein can decelerate the aggregation kinetics of the H50Q variant in a dose-dependent manner when coaggregating with it. These last findings suggest that the precise balance of α-synuclein synthesized from the wild-type and mutant alleles may influence the natural history and heterogeneous clinical phenotype of Parkinson disease. Background The basis of the pathogenicity of the H50Q variant α-synuclein is unknown. Results The critical concentration of α-synuclein is decreased by 10-fold by the H50Q mutation, and its aggregation is modulated by the wild-type isoform. Conclusion Key effects of the H50Q mutation on the aggregation of α-synuclein can be quantified. Significance Our data provide insights into the mechanism of Lewy body formation in vivo .
Cited by 77 works. doi:10.1074/jbc.m114.610527 Open-access PDF
Authors
- Riccardo Porcari
- Christos Proukakis
- Christopher A. Waudby
- Benedetta Bolognesi
- Palma Patrizia Mangione
- Stephen Mullin
- Lisa D. Cabrita
- Amanda Penco
- Annalisa Relini
- Guglielmo Verona
- Michele Vendruscolo
- Monica Stoppini
- Gian Gaetano Tartaglia
- Carlo Camilloni
- John Christodoulou
- Anthony H.V. Schapira
- Vittorio Bellotti
References
- NMRPipe: A multidimensional spectral processing system based on UNIX pipes
- Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
- α-Synuclein in Lewy bodies
- AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease
- α-Synuclein Locus Triplication Causes Parkinson's Disease
- α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodies
- A theory of linear and helical aggregations of macromolecules
- Hydrophobicity of Amino Acid Residues in Globular Proteins
- NACP, A Protein Implicated in Alzheimer's Disease and Learning, Is Natively Unfolded
- Surface and inside volumes in globular proteins